UNSPSC 85892644: High dose rate (hdr) brachytherapy of diaphragm using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of diaphragm using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DB189BZ

UNSPSC 85892644 High dose rate brachytherapy of diaphragm using palladium 103 (pd-103) is a Commodity code whose nominal scope describes a specialized oncology procedure, but the most recent state and local procurement activity under this code shows a substantial mismatch: the County of Santa Clara Health System's July 2026 solicitation (RFSQHHSFY270052) seeks temporary health professional staffing services across multiple ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, orthopedics, respiratory care, and surgical services — work unrelated to brachytherapy. The code appears to capture a broad range of health system staffing needs rather than the specific high-dose-rate brachytherapy procedure its name suggests. State and local health systems use this code to solicit qualified vendor pools for clinical staff augmentation, establishing non-exclusive multiple-award vehicles with no guaranteed work volume and selections made on a case-by-case basis as operational needs arise.

The Santa Clara Health System's October 2026 response deadline represents the only recent state and local opportunity identified under this code. Proposers may self-select and submit qualifications for all or specific health professional categories without penalty, and the Health System reserves the right to maintain the Qualified List for up to five years. The solicitation explicitly excludes nursing, physician, and other non-clinical staffing, and all proposals must be submitted electronically. The mismatch between the code's nominal scope and the actual work being solicited suggests this code may not be decision-relevant for vendors focused on brachytherapy or related oncology services; activity under this code warrants verification that opportunities align with firm capability before pursuing.